After receiving a PhD in Genetics from George Washington University, Clay Siegall started his long career in the field of biotechnology. His strong desire to help find better treatments for cancer patients is what led him to start his own biotechnology company in 1998 called Seattle Genetics. The company is focused on developing antibody-based therapies that can be used to treat many forms of cancer, including Hodgkin lymphoma. Seattle Genetics came up with the drug called Adcetris, which is also known as brentuximab vedotin. The drug has been approved in both the U.S. and Canada by the Food and Drug Administration and by Health Canada.
Prior to starting his own innovative company geared toward improving the lives of those who are suffering from cancer, Clay Siegall worked in several other companies that are involved with research and therapeutic drug development, such as Bristol-Myers Squibb Pharmaceutical Research Institute, where he was the Senior Research Investigator from 1991 to 1995. He has been the President of Seattle Genetics since the year 2000, and he became its CEO in 2002. He currently holds 15 patents that are based on his innovative creations in the world of science, and he has authored nearly 70 research papers.
Clay Siegall also serves on the board of directors at a private company called Alder BioPharmaceuticals, and he runs a blog on the WordPress website that covers a spectrum of topics that involve innovations in science, including new drug therapies for certain diseases. His 30 years of experience in the field of scientific research has not only helped him gain more understanding about what is needed to treat the disease of cancer in a more effective way, but it has also brought him numerous honors and awards that include Entrepreneur of the Year and Alumnus of the Year for Computer, Math and Natural Sciences.
In addition to receiving a degree in Genetics. Clay Siegall also has a BS degree in Zoology from the University of Maryland. He’s said that his idea to start Seattle Genetics came from watching his father suffer from cancer and succumb to the disease years ago.